SOSV

Flow Neuroscience AB is a healthcare company based in Malmö, Sweden, focused on developing innovative treatment solutions for depression. Established in 2011, the company creates a wearable device that delivers transcranial direct current stimulation (tDCS) to the forehead, targeting the left frontal lobe, an area often associated with reduced activity in individuals suffering from major depressive disorder (MDD). This headset is complemented by a personalized mobile application designed to encourage users to adopt healthier daily routines, such as improved sleep patterns and increased physical activity. By combining brain stimulation with behavioral therapy, Flow Neuroscience aims to provide a medication-free treatment option that is accessible and affordable, challenging the traditional pharmaceutical approaches to depression. The company aspires to make these effective treatments widely available, moving beyond the confines of specialized clinics.

Sundew is a biotechnology company founded in 2018 and headquartered in Copenhagen. The company specializes in providing biological services designed to treat aquatic pests and diseases through innovative solutions. Utilizing precision fermentation, Sundew develops environmentally-friendly products aimed at addressing challenges in the aquaculture market, including the management of invasive species and ecological issues such as red tides. By focusing on unmet needs within this sector, Sundew enables its clients to create effective, cost-efficient solutions that are both climate-friendly and sustainable.

CroBio Ltd is an agricultural biotechnology company based in Macclesfield, United Kingdom, founded in 2019 by experts in microbiology and engineering. The company focuses on developing environmentally sustainable solutions to combat global agricultural drought. Its technology leverages genetically engineered root-associated bacteria that produce a sponge-like biomaterial, facilitating biologically active water retention in soil. This innovative approach aims to improve soil health and enhance water management in agricultural practices.

NuKoKo is a bean-to-bar manufacturing company specializing in cocoa-free chocolate. By utilizing ingredients sourced from the UK, the company has developed a patent-pending technology that allows for the production of a novel type of chocolate. This innovative product is designed to be healthier and has a significantly reduced environmental impact compared to traditional chocolate production methods. NuKoKo's offerings are characterized by low carbon emissions, low sugar content, and high protein, catering to consumers seeking sustainable and nutritious alternatives in the chocolate market.

Samphire Neuroscience provides solutions that specialize in women's health. The company was founded in 2021 and is based in London, England.

CargoKite offers micro cargo ships to enable flexible maritime logistics. The company was founded in 2022 and is based in Munich, Germany.

Valanx Biotech GmbH, founded in 2017 and located in Klosterneuburg, Austria, specializes in the development and manufacture of synthetic programmable amino acids, particularly Norl. The company has created SnapIt, a reactive amino acid that facilitates the conjugation of antibodies with medicines, resulting in antibody-drug conjugates aimed at treating cancer. In addition to cancer therapy, Valanx's products are utilized for PEGylation of therapeutic peptides and proteins, as well as for the directed and oriented immobilization of biocatalysts and biosensors. The company also offers on-demand bioanalytics and mass spectrometry services. Valanx Biotech's site-specific protein conjugation platform aims to streamline the development of protein-drug conjugates, making the process faster and more cost-effective, ultimately allowing healthcare providers to produce receptor proteins with specific chemical modifications.

NuKoKo is a bean-to-bar manufacturing company specializing in cocoa-free chocolate. By utilizing ingredients sourced from the UK, the company has developed a patent-pending technology that allows for the production of a novel type of chocolate. This innovative product is designed to be healthier and has a significantly reduced environmental impact compared to traditional chocolate production methods. NuKoKo's offerings are characterized by low carbon emissions, low sugar content, and high protein, catering to consumers seeking sustainable and nutritious alternatives in the chocolate market.

Reach Industries, founded in 2020 and headquartered in Bristol, UK, is a software development company that specializes in creating advanced products for laboratories. The company develops a platform aimed at enhancing productivity and quality in lab environments. Its robotics software supports scientists by improving laboratory efficiency through features such as predictive quality and maintenance analytics, asset condition monitoring, and process optimization. This innovative approach enables clients to effectively manage material flow and securely store telematics and sensor data in the cloud.

Valanx Biotech GmbH, founded in 2017 and located in Klosterneuburg, Austria, specializes in the development and manufacture of synthetic programmable amino acids, particularly Norl. The company has created SnapIt, a reactive amino acid that facilitates the conjugation of antibodies with medicines, resulting in antibody-drug conjugates aimed at treating cancer. In addition to cancer therapy, Valanx's products are utilized for PEGylation of therapeutic peptides and proteins, as well as for the directed and oriented immobilization of biocatalysts and biosensors. The company also offers on-demand bioanalytics and mass spectrometry services. Valanx Biotech's site-specific protein conjugation platform aims to streamline the development of protein-drug conjugates, making the process faster and more cost-effective, ultimately allowing healthcare providers to produce receptor proteins with specific chemical modifications.

Samphire Neuroscience provides solutions that specialize in women's health. The company was founded in 2021 and is based in London, England.

Sundew is a biotechnology company founded in 2018 and headquartered in Copenhagen. The company specializes in providing biological services designed to treat aquatic pests and diseases through innovative solutions. Utilizing precision fermentation, Sundew develops environmentally-friendly products aimed at addressing challenges in the aquaculture market, including the management of invasive species and ecological issues such as red tides. By focusing on unmet needs within this sector, Sundew enables its clients to create effective, cost-efficient solutions that are both climate-friendly and sustainable.

Vitarka Therapeutics develops medical technology and solutions for various types of cancer. It is based in London, United Kingdom.

PILI Inc. is a company based in Paris, France, that specializes in researching and manufacturing bio-fabricated colors derived from microorganisms. Founded in 2012, the company focuses on designing enzymes and fermentation biotechnologies that convert sugar into sustainable and long-lasting dyes and pigments. PILI produces renewable inks as an eco-friendly alternative to traditional toxic and non-recyclable options. The company emerged from a collaboration among a biologist, a designer, and a financial analyst in a biohacker space, leading to the creation of innovative products like a pen fed by bacteria. By utilizing microorganisms, PILI aims to replace petrochemical and non-sustainable vegetable dyes, promoting sustainable development while also helping businesses reduce costs.

CroBio Ltd is an agricultural biotechnology company based in Macclesfield, United Kingdom, founded in 2019 by experts in microbiology and engineering. The company focuses on developing environmentally sustainable solutions to combat global agricultural drought. Its technology leverages genetically engineered root-associated bacteria that produce a sponge-like biomaterial, facilitating biologically active water retention in soil. This innovative approach aims to improve soil health and enhance water management in agricultural practices.

Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016 and based in Barcelona, Spain, the company specializes in creating non-invasive tests for the in-situ diagnosis of various cancers using patients' blood. It also develops in-vivo diagnosis systems that assist in surgical procedures and monitor patient conditions, alongside therapeutical drugs aimed at treating cancer. Moirai Biodesign's innovative pipeline includes RNA biomarker discovery, the design of plug-and-play bio devices, and advanced platform delivery systems, all aimed at improving early cancer detection and targeted treatment options.

Japet Medical Devices is a French biomedical company focused on developing innovative robotic equipment aimed at enhancing treatment quality. The company specializes in wearable robotic exoskeletons that integrate medical and robotic technologies to assist with both occupational and daily health needs. These exoskeletons are designed to restore balance and facilitate free movement, offering pain relief through orthotic support. Japet's commitment to creating user-friendly solutions reflects its belief in the transformative potential of these technologies to improve the quality of life for many individuals.

Multus is a London-based company established in 2019 that specializes in providing affordable and efficient growth media for the cultivated meat industry. By employing a machine learning approach, Multus develops entirely animal-free growth media tailored specifically for animal cells, helping cultivated meat companies scale their production while maintaining high performance. The company focuses on optimizing growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the environmental drawbacks associated with traditional animal serum-based media. This innovative solution supports the growth of diverse animal cell types and tissues, enabling clients to produce sustainable meat products while minimizing the environmental and economic impacts of conventional meat production.

QV Bioelectronics is focused on improving the lives of brain tumor patients through its innovative electric field therapy implant, GRACE. Developed in collaboration with leading neurosurgeons in the UK, GRACE aims to extend the life expectancy of glioblastoma patients, a group historically faced with limited treatment options and poor survival rates. Recognizing the urgent need for effective therapies, co-founders Dr. Richard Fu and Dr. Chris Bullock created a solution to address both the clinical and quality of life challenges faced by patients. The company has garnered nearly $1 million in funding from UK institutions, including Innovate UK, and over $1 million in equity funding from international life science investors. With a multidisciplinary team based in Alderley Park, Cheshire, QV Bioelectronics is dedicated to advancing GRACE from research to clinical application, utilizing cutting-edge materials science to enhance treatment outcomes for patients.

NuKoKo is a bean-to-bar manufacturing company specializing in cocoa-free chocolate. By utilizing ingredients sourced from the UK, the company has developed a patent-pending technology that allows for the production of a novel type of chocolate. This innovative product is designed to be healthier and has a significantly reduced environmental impact compared to traditional chocolate production methods. NuKoKo's offerings are characterized by low carbon emissions, low sugar content, and high protein, catering to consumers seeking sustainable and nutritious alternatives in the chocolate market.

Metabolomic Diagnostics Ltd. is a medical diagnostics company based in Little Island, Ireland, founded in 2011. The company specializes in developing advanced diagnostic solutions that utilize mass spectrometry technology to analyze biomarkers associated with complex diseases. Its primary focus is on providing predictive diagnoses for pre-eclampsia in early pregnancy through a blood test that assesses the risk of this condition, which can lead to serious complications such as hypertension and restricted blood flow to the fetus. Metabolomic Diagnostics has established a pipeline for identifying diagnostic biomarker panels and translating these findings into clinical assays suitable for use in laboratory settings, thus enabling effective disease diagnosis and risk prediction.

Oxyle AG is a Swiss company based in Zurich that specializes in wastewater treatment aimed at removing persistent and toxic micropollutants from water sources. Established in 2020, the company has developed a novel technology that effectively degrades hazardous substances, including pharmaceuticals, personal-care products, endocrine-disrupting chemicals, pesticides, and industrial chemicals. Oxyle serves a diverse clientele, including the pharmaceutical, biotech, chemical, food and beverage sectors, research laboratories, hospitals, and wastewater treatment facilities. Its innovative approach not only helps clients comply with regulatory standards but also offers a sustainable alternative to wastewater incineration, thereby contributing to reduced CO2 emissions.

Vitarka Therapeutics develops medical technology and solutions for various types of cancer. It is based in London, United Kingdom.

Hexafly is a biotechnology company based in Kells, Ireland, that focuses on developing sustainable products derived from the farming of Black Soldier Fly larvae. Established in 2016, Hexafly operates within the circular economy by converting food waste into valuable resources, including insect oil and protein for aquaculture and animal feed, as well as Frass, a plant nutrition compound. The company also produces Chitin, a biopolymer used in pharmaceuticals, cosmetics, and food additives. By offering these products online, Hexafly aims to provide sustainable solutions for the aquaculture, animal feed, and plant nutrition industries, contributing to a more sustainable food system for animals and, ultimately, humans.

Samphire Neuroscience provides solutions that specialize in women's health. The company was founded in 2021 and is based in London, England.

Machine Medicine Technologies Ltd is a healthcare company that develops an artificial intelligence platform designed to assess motor characteristics in Parkinson's disease patients using video clips. Its flagship product, KELVIN-PD, employs computer vision and pose estimation techniques to objectively track patient movements, capturing key metrics related to symptoms such as tremors and bradykinesia. This platform facilitates the secure storage and management of patient data and is accessible from any device, making it both affordable and user-friendly. Established in 2017 and headquartered in London, the company aims to enhance the understanding of the brain and advance neuro-therapeutics by providing interpretable tools for behavioral measurement.

Reach Industries, founded in 2020 and headquartered in Bristol, UK, is a software development company that specializes in creating advanced products for laboratories. The company develops a platform aimed at enhancing productivity and quality in lab environments. Its robotics software supports scientists by improving laboratory efficiency through features such as predictive quality and maintenance analytics, asset condition monitoring, and process optimization. This innovative approach enables clients to effectively manage material flow and securely store telematics and sensor data in the cloud.

ChronosDx is a biotechnology research company based in London, Germany, specializing in drug development and in vitro diagnostics. The firm focuses on creating bioassay technology tailored for diagnostics, drug screening, and development. ChronosDx develops high-performance, cost-effective, and scalable technology that effectively detects various biomarkers, including cell-free DNA, micro proteins, exosomes, and metabolites. This innovative platform enables medical professionals to monitor biomarkers both in-line and in vivo, enhancing the capabilities of healthcare diagnostics.

Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016 and based in Barcelona, Spain, the company specializes in creating non-invasive tests for the in-situ diagnosis of various cancers using patients' blood. It also develops in-vivo diagnosis systems that assist in surgical procedures and monitor patient conditions, alongside therapeutical drugs aimed at treating cancer. Moirai Biodesign's innovative pipeline includes RNA biomarker discovery, the design of plug-and-play bio devices, and advanced platform delivery systems, all aimed at improving early cancer detection and targeted treatment options.

XFuel is a company that specializes in producing sustainable and net-zero drop-in fuels for road, marine, and aviation applications. Founded in 2010 and headquartered in Dublin, Ireland, with a presence in Palma de Mallorca, Spain, XFuel has developed innovative technology for the efficient and cost-effective conversion of biomass waste into low-carbon fuels. The company’s advanced fuels generate up to 85% fewer greenhouse gas emissions compared to conventional fossil fuel production, positioning them as a cleaner alternative in the transport sector. By providing decentralized and sustainable fuel solutions, XFuel aims to support distributors and consumers globally in reducing reliance on fossil fuels while working towards carbon-neutral and even carbon-negative fuel options.

CargoKite offers micro cargo ships to enable flexible maritime logistics. The company was founded in 2022 and is based in Munich, Germany.

SensiPass Ltd. specializes in developing advanced 3-factor authentication solutions aimed at enhancing digital security for various industries, including energy, transportation, communications, government, and defense. Established in 2013 and headquartered in Dublin, Ireland, the company addresses significant challenges related to identity theft and insider threats by replacing traditional passwords and PINs with a personalized human interaction model. By registering a user's device, biometric data, and a unique interaction, SensiPass generates a sophisticated digital signature that is secure and non-reproducible. This innovative approach allows for quick authentication, providing identity assurance in both digital and physical access scenarios. The company's patented technologies, such as SensiAR™ and ImmersiveID™, cater to immersive environments, reinforcing security for critical infrastructure and utilities. SensiPass has received recognition for its contributions to cybersecurity innovation, including accolades from Deloitte and other industry organizations.

QV Bioelectronics is focused on improving the lives of brain tumor patients through its innovative electric field therapy implant, GRACE. Developed in collaboration with leading neurosurgeons in the UK, GRACE aims to extend the life expectancy of glioblastoma patients, a group historically faced with limited treatment options and poor survival rates. Recognizing the urgent need for effective therapies, co-founders Dr. Richard Fu and Dr. Chris Bullock created a solution to address both the clinical and quality of life challenges faced by patients. The company has garnered nearly $1 million in funding from UK institutions, including Innovate UK, and over $1 million in equity funding from international life science investors. With a multidisciplinary team based in Alderley Park, Cheshire, QV Bioelectronics is dedicated to advancing GRACE from research to clinical application, utilizing cutting-edge materials science to enhance treatment outcomes for patients.

MotionsCloud specializes in utilizing computer vision and artificial intelligence technology to automate the assessment of car and property damage for insurance companies. By streamlining the claims process, MotionsCloud significantly reduces the claim cycle time from 10 days to just 3 hours and can lower claims processing costs by up to 75%. This innovative approach not only enhances operational efficiency for insurers but also improves the overall customer claims experience. The company currently serves clients across the United States, Europe, and Southeast Asia, demonstrating its global reach and impact in the insurance sector.

IPOR Labs, located in Zug, Switzerland, focuses on the development of blockchain-based derivatives software aimed at fixing interest rates. The company's primary offering, the IPOR Protocol, encompasses three key components: the IPOR Index, Interest Rate Derivative(s), and a Liquidity Pool with an Automated Market Maker. This innovative software allows users to engage in interest rate swaps, providing them the option to pay either a fixed or floating rate based on the current IPOR rate. By leveraging a liquidity pool as a contract counterparty, IPOR Labs enables participants to gain a transparent understanding and greater control over interest rate markets, enhancing the efficiency and accessibility of decentralized finance (DeFi).

Metabolomic Diagnostics Ltd. is a medical diagnostics company based in Little Island, Ireland, founded in 2011. The company specializes in developing advanced diagnostic solutions that utilize mass spectrometry technology to analyze biomarkers associated with complex diseases. Its primary focus is on providing predictive diagnoses for pre-eclampsia in early pregnancy through a blood test that assesses the risk of this condition, which can lead to serious complications such as hypertension and restricted blood flow to the fetus. Metabolomic Diagnostics has established a pipeline for identifying diagnostic biomarker panels and translating these findings into clinical assays suitable for use in laboratory settings, thus enabling effective disease diagnosis and risk prediction.

AromatEco assists household brands in becoming more environmentally friendly by delivering renewable flavors and perfumes. Headquartered in London, UK.

Sundew is a biotechnology company founded in 2018 and headquartered in Copenhagen. The company specializes in providing biological services designed to treat aquatic pests and diseases through innovative solutions. Utilizing precision fermentation, Sundew develops environmentally-friendly products aimed at addressing challenges in the aquaculture market, including the management of invasive species and ecological issues such as red tides. By focusing on unmet needs within this sector, Sundew enables its clients to create effective, cost-efficient solutions that are both climate-friendly and sustainable.

Hexafly is a biotechnology company based in Kells, Ireland, that focuses on developing sustainable products derived from the farming of Black Soldier Fly larvae. Established in 2016, Hexafly operates within the circular economy by converting food waste into valuable resources, including insect oil and protein for aquaculture and animal feed, as well as Frass, a plant nutrition compound. The company also produces Chitin, a biopolymer used in pharmaceuticals, cosmetics, and food additives. By offering these products online, Hexafly aims to provide sustainable solutions for the aquaculture, animal feed, and plant nutrition industries, contributing to a more sustainable food system for animals and, ultimately, humans.

ROVENSO is a Swiss startup from EPFL (Swiss Federal Institute of Technology Lausanne) incorporated in 2016.We are based near Lausanne (Switzerland). We develop, manufacture and market ROVéo, an agile robot for security and safety monitoring of industrial sites.ROVéo patrols fully autonomously 24/7, 2-3x more cost-effective than manned guarding, inside and outside industrial buildings, preventing intrusions, detecting any thefts of assets, but also detecting safety hazards such as start of fires, leaks or systems dysfunctions that could put people’s life at risks and that could be even missed by security guards.

Quidli is a technological infrastructure company based in Paris, France, that focuses on connecting companies and workers through the exchange of equity for labor. Founded in 2018, Quidli's platform allows businesses to split ownership equity as a form of compensation, facilitating a direct link between companies, freelancers, and investors. By leveraging blockchain technology, the platform provides a means for organizations to incentivize contributions from individuals, enhancing employee engagement and productivity. Additionally, it offers job security for workers by allowing them to pursue projects of their choice, while companies can utilize the platform for recruitment purposes.

Valanx Biotech GmbH, founded in 2017 and located in Klosterneuburg, Austria, specializes in the development and manufacture of synthetic programmable amino acids, particularly Norl. The company has created SnapIt, a reactive amino acid that facilitates the conjugation of antibodies with medicines, resulting in antibody-drug conjugates aimed at treating cancer. In addition to cancer therapy, Valanx's products are utilized for PEGylation of therapeutic peptides and proteins, as well as for the directed and oriented immobilization of biocatalysts and biosensors. The company also offers on-demand bioanalytics and mass spectrometry services. Valanx Biotech's site-specific protein conjugation platform aims to streamline the development of protein-drug conjugates, making the process faster and more cost-effective, ultimately allowing healthcare providers to produce receptor proteins with specific chemical modifications.

Samphire Neuroscience provides solutions that specialize in women's health. The company was founded in 2021 and is based in London, England.

Reach Industries, founded in 2020 and headquartered in Bristol, UK, is a software development company that specializes in creating advanced products for laboratories. The company develops a platform aimed at enhancing productivity and quality in lab environments. Its robotics software supports scientists by improving laboratory efficiency through features such as predictive quality and maintenance analytics, asset condition monitoring, and process optimization. This innovative approach enables clients to effectively manage material flow and securely store telematics and sensor data in the cloud.

Criam is a biotechnology company based in Braga, Portugal, founded in 2015. It specializes in the research and development of a medical device designed for blood type analysis and the detection of infectious diseases. The company's flagship product offers rapid and accurate testing for various conditions, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. This portable device operates independently of electricity or laboratory infrastructure, making it accessible for use in diverse environments. Additionally, Criam's technology is scalable, allowing a single reader to perform multiple tests using specific cartridges and advanced computer vision algorithms. By optimizing blood testing services, Criam aims to provide timely health information and improve clinical decision-making.

Ostoform is a spin-out medical device company from the University of Limerick, Ireland with a range of patented technologies, and the potential to scale, becoming a global leader in the area of ostomy skin health.

Kyomei is a company based in Oxford, England, founded in 2021, that focuses on developing a plant-based production system aimed at creating animal proteins for the alternative meat industry. Utilizing innovative plant cell biology, Kyomei employs a unique method to scale the production of myoglobin in plants, which enhances the umami flavor of meat alternatives. This approach not only improves the taste of plant-based products but also supports efforts to reduce carbon emissions associated with traditional animal farming. Through its sustainable practices, Kyomei aims to provide consumers with flavorful plant-based meat options while contributing to a more environmentally friendly food system.

EMYS is the most advanced, English speaking educational robot in the world with a friendly appearance and outstanding interactive capabilities. Children aged 3-7 years old simply love EMYS! The robot is a rich source of carefully chosen language presented through a series of interactive tasks, games, crafts, activities, songs and stories. The mission of EMYS Inc. is to shape the future of education through the world's most innovative, secure and hands-on technology. The EMYS team of highly qualified experts in the domains of English Language Education as well as Social Robotics pushes back the boundaries of Early Years Language Education programs. We are the first to combine modern research in language acquisition studies with Common European Framework requirements and the most advanced technology. Parents appreciate the assistance EMYS provides in getting kids constructively busy.They also observe a lasting engagement with language learning through the bond that children build with their robot. Children love learning with EMYS and quickly master the skills needed to play with their digital room-mate independently. EMYS' rich programme can be easily incorporated in diverse curricula. The included teachers’ books serve as inspiration for truly engaging classes. In EMYS classrooms worldwide there has been observed: - a significant increase in group focus - strengthened motivation in young learners - increased in-class satisfaction levels. EMYS is sold world-wide and our offices are located in the USA, Europe and Asia.

Kutanios is a biotechnology company based in London that specializes in the development of innovative compounds for various skincare applications, including anti-aging, sun protection, and anti-acne treatments. The firm focuses on creating biodegradable molecules that utilize a novel mechanism of action, which targets lipid peroxides generated by environmental factors such as sunlight, pollution, and tobacco smoke. By employing green technology in the manufacturing process, Kutanios aims to provide effective solutions that help prevent skin aging, sunburn, and skin cancers, catering to the needs of consumers seeking safer and more effective skincare options.

VoltStorage GmbH, based in Olching, Germany, specializes in developing and producing power storage devices that utilize eco-friendly redox flow technology. The company's flagship product, VoltStorage, is a vanadium redox flow battery system designed to store excess electricity generated by solar panels during the day for use at night. This innovative approach enables homeowners to access renewable energy around the clock, promoting sustainability and environmental responsibility. In addition to its products, VoltStorage offers installation and technical support services, ensuring customers can effectively integrate these systems into their homes. The company aims to make renewable energy more accessible and contribute to a cleaner, fairer world for future generations.

Multus is a London-based company established in 2019 that specializes in providing affordable and efficient growth media for the cultivated meat industry. By employing a machine learning approach, Multus develops entirely animal-free growth media tailored specifically for animal cells, helping cultivated meat companies scale their production while maintaining high performance. The company focuses on optimizing growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the environmental drawbacks associated with traditional animal serum-based media. This innovative solution supports the growth of diverse animal cell types and tissues, enabling clients to produce sustainable meat products while minimizing the environmental and economic impacts of conventional meat production.

Japet Medical Devices is a French biomedical company focused on developing innovative robotic equipment aimed at enhancing treatment quality. The company specializes in wearable robotic exoskeletons that integrate medical and robotic technologies to assist with both occupational and daily health needs. These exoskeletons are designed to restore balance and facilitate free movement, offering pain relief through orthotic support. Japet's commitment to creating user-friendly solutions reflects its belief in the transformative potential of these technologies to improve the quality of life for many individuals.

QV Bioelectronics is focused on improving the lives of brain tumor patients through its innovative electric field therapy implant, GRACE. Developed in collaboration with leading neurosurgeons in the UK, GRACE aims to extend the life expectancy of glioblastoma patients, a group historically faced with limited treatment options and poor survival rates. Recognizing the urgent need for effective therapies, co-founders Dr. Richard Fu and Dr. Chris Bullock created a solution to address both the clinical and quality of life challenges faced by patients. The company has garnered nearly $1 million in funding from UK institutions, including Innovate UK, and over $1 million in equity funding from international life science investors. With a multidisciplinary team based in Alderley Park, Cheshire, QV Bioelectronics is dedicated to advancing GRACE from research to clinical application, utilizing cutting-edge materials science to enhance treatment outcomes for patients.

Intelligent Implants, founded in 2014 in Cork, Ireland, specializes in the development of wireless implantable electronics designed to stimulate, steer, and monitor bone growth. The company focuses on creating electrotherapeutic devices that not only treat diseases but also support the recovery of bone and other tissues. By integrating data, engineering, and medicine, Intelligent Implants aims to deliver innovative, active, and connected medical devices that enhance patient treatment and facilitate decision-making for healthcare professionals. Their technology allows for the acceleration and adjustment of bone growth, enabling healthcare providers to effectively utilize electrotherapeutics to monitor and control patient conditions, ultimately leading to more timely and informed medical interventions.

All the health information we need is within us. Just below the skin. SAVA is redefining the way people interact with their health by developing the most advanced biosensing technology science has to offer, capable of accessing bodily information in a painless, real-time and affordable way.

Maven is a SaaS pet tech startup that provides a personal vet to track the pet’s safety and health 24/7. It focuses on using technology to improve the quality of life for pets, as well as offering pet owners peace of mind and a way to keep track of their pet's safety, health, and well-being on a continual basis through their own personal veterinarian. It was started by the founders of Findster Technologies in 2021 and is based in the US and Portugal.

Multus is a London-based company established in 2019 that specializes in providing affordable and efficient growth media for the cultivated meat industry. By employing a machine learning approach, Multus develops entirely animal-free growth media tailored specifically for animal cells, helping cultivated meat companies scale their production while maintaining high performance. The company focuses on optimizing growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the environmental drawbacks associated with traditional animal serum-based media. This innovative solution supports the growth of diverse animal cell types and tissues, enabling clients to produce sustainable meat products while minimizing the environmental and economic impacts of conventional meat production.

DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in developing artificial intelligence-powered magnetic resonance imaging (MRI) equipment. The company’s innovative technology aims to provide MRI imaging systems that are significantly smaller, lighter, and more cost-effective than traditional models. By leveraging generative topological design and deep learning techniques, DeepSpin's MRI machines enhance accessibility to medical imaging, making it available to a wider range of patients globally. This approach seeks to improve healthcare standards in various medical fields previously lacking adequate imaging solutions.

Hexafly is a biotechnology company based in Kells, Ireland, that focuses on developing sustainable products derived from the farming of Black Soldier Fly larvae. Established in 2016, Hexafly operates within the circular economy by converting food waste into valuable resources, including insect oil and protein for aquaculture and animal feed, as well as Frass, a plant nutrition compound. The company also produces Chitin, a biopolymer used in pharmaceuticals, cosmetics, and food additives. By offering these products online, Hexafly aims to provide sustainable solutions for the aquaculture, animal feed, and plant nutrition industries, contributing to a more sustainable food system for animals and, ultimately, humans.

viAct is an AI company focused on delivering scenario-based vision intelligence solutions for the architecture, engineering, and construction (AEC) industry across Asia, Europe, and the Middle East. Since its establishment in 2016, the company has successfully implemented hundreds of deployments, utilizing proprietary AI algorithms to provide detailed insights into job sites. viAct offers over 30 pre-built AI modules that help stakeholders enhance safety, reduce accidents, optimize costs, and monitor environmental compliance. Their applications track site activities, ensure adherence to safety measures, and identify irregularities, contributing to improved efficiency and personnel safety in construction projects.

Nordetect, based in Copenhagen and founded in 2016, is an analytical hardware company that specializes in Lab-on-a-chip devices designed for environmental and agricultural analysis. The company aims to integrate medical-grade technology into the farming sector, offering solutions for nutrient analysis to optimize crop performance. Nordetect's technology enables farm managers, agricultural service providers, and indoor growers to conduct reliable and affordable testing of soil nutrients, specifically nitrogen, phosphorus, and potassium. By providing clear and actionable data, the company helps users make informed decisions about fertilizer usage and agricultural practices, ultimately leading to improved harvests.

Nordetect, based in Copenhagen and founded in 2016, is an analytical hardware company that specializes in Lab-on-a-chip devices designed for environmental and agricultural analysis. The company aims to integrate medical-grade technology into the farming sector, offering solutions for nutrient analysis to optimize crop performance. Nordetect's technology enables farm managers, agricultural service providers, and indoor growers to conduct reliable and affordable testing of soil nutrients, specifically nitrogen, phosphorus, and potassium. By providing clear and actionable data, the company helps users make informed decisions about fertilizer usage and agricultural practices, ultimately leading to improved harvests.

EMYS is the most advanced, English speaking educational robot in the world with a friendly appearance and outstanding interactive capabilities. Children aged 3-7 years old simply love EMYS! The robot is a rich source of carefully chosen language presented through a series of interactive tasks, games, crafts, activities, songs and stories. The mission of EMYS Inc. is to shape the future of education through the world's most innovative, secure and hands-on technology. The EMYS team of highly qualified experts in the domains of English Language Education as well as Social Robotics pushes back the boundaries of Early Years Language Education programs. We are the first to combine modern research in language acquisition studies with Common European Framework requirements and the most advanced technology. Parents appreciate the assistance EMYS provides in getting kids constructively busy.They also observe a lasting engagement with language learning through the bond that children build with their robot. Children love learning with EMYS and quickly master the skills needed to play with their digital room-mate independently. EMYS' rich programme can be easily incorporated in diverse curricula. The included teachers’ books serve as inspiration for truly engaging classes. In EMYS classrooms worldwide there has been observed: - a significant increase in group focus - strengthened motivation in young learners - increased in-class satisfaction levels. EMYS is sold world-wide and our offices are located in the USA, Europe and Asia.

viAct is an AI company focused on delivering scenario-based vision intelligence solutions for the architecture, engineering, and construction (AEC) industry across Asia, Europe, and the Middle East. Since its establishment in 2016, the company has successfully implemented hundreds of deployments, utilizing proprietary AI algorithms to provide detailed insights into job sites. viAct offers over 30 pre-built AI modules that help stakeholders enhance safety, reduce accidents, optimize costs, and monitor environmental compliance. Their applications track site activities, ensure adherence to safety measures, and identify irregularities, contributing to improved efficiency and personnel safety in construction projects.

Flow Neuroscience AB is a healthcare company based in Malmö, Sweden, focused on developing innovative treatment solutions for depression. Established in 2011, the company creates a wearable device that delivers transcranial direct current stimulation (tDCS) to the forehead, targeting the left frontal lobe, an area often associated with reduced activity in individuals suffering from major depressive disorder (MDD). This headset is complemented by a personalized mobile application designed to encourage users to adopt healthier daily routines, such as improved sleep patterns and increased physical activity. By combining brain stimulation with behavioral therapy, Flow Neuroscience aims to provide a medication-free treatment option that is accessible and affordable, challenging the traditional pharmaceutical approaches to depression. The company aspires to make these effective treatments widely available, moving beyond the confines of specialized clinics.

TIER Mobility GmbH is a shared micro-mobility provider based in Berlin, Germany, specializing in electric vehicles for local commuting. Founded in 2018, the company offers a variety of light electric vehicles, including e-scooters, e-bikes, and e-mopeds, all accessible through a user-friendly application that allows customers to locate and book vehicles easily. TIER aims to transform urban transportation by reducing reliance on cars and promoting climate-neutral solutions that contribute to a sustainable future. Through its proprietary Energy Network, TIER is committed to fostering environmentally friendly mobility options in cities.

Magellan Life Sciences Ltd. is a synthetic biology company based in London, United Kingdom, specializing in the development of plant-based proteins for the food and beverage industries. Established in 2018, the company focuses on creating innovative protein sweeteners, including brazzein, utilizing its proprietary protein engineering and expression platforms. These novel protein-based molecules are designed to offer non-calorific alternatives that address sugar content and associated health concerns. By providing advanced solutions for the food, health, and nutrition sectors, Magellan Life Sciences aims to meet the growing demand for healthier ingredients in consumer products.

Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016 and based in Barcelona, Spain, the company specializes in creating non-invasive tests for the in-situ diagnosis of various cancers using patients' blood. It also develops in-vivo diagnosis systems that assist in surgical procedures and monitor patient conditions, alongside therapeutical drugs aimed at treating cancer. Moirai Biodesign's innovative pipeline includes RNA biomarker discovery, the design of plug-and-play bio devices, and advanced platform delivery systems, all aimed at improving early cancer detection and targeted treatment options.

Aō Air specializes in the manufacture and retail of advanced face masks aimed at providing clean air for individuals in polluted megacities such as Beijing and London. The company utilizes patented air purifying technology, which has been independently validated to be significantly more effective than traditional masks, filtering out dust and smoke particles through an active nanofiltration system. This innovative approach allows users to commute and exercise without the risks associated with pollution, promoting respiratory health while ensuring comfort and style. Aō Air's mission focuses on empowering urban residents to reclaim their environment and breathe clean air amidst increasing urban pollution challenges.

Nordetect, based in Copenhagen and founded in 2016, is an analytical hardware company that specializes in Lab-on-a-chip devices designed for environmental and agricultural analysis. The company aims to integrate medical-grade technology into the farming sector, offering solutions for nutrient analysis to optimize crop performance. Nordetect's technology enables farm managers, agricultural service providers, and indoor growers to conduct reliable and affordable testing of soil nutrients, specifically nitrogen, phosphorus, and potassium. By providing clear and actionable data, the company helps users make informed decisions about fertilizer usage and agricultural practices, ultimately leading to improved harvests.

Babybe GmbH is a medical device company based in Stuttgart, Germany, that specializes in products designed for premature babies and their mothers. Founded in 2013 by Raphael P. M. Lang and Camilo Anabalon, the company developed the Babybe System, a unique bionic mattress that simulates the mother's heartbeat, breathing, and voice, providing multisensory stimulation to preterm infants during their time in incubators. This innovative device facilitates a real-time connection between mother and child, enhancing the baby's recovery process and neurodevelopmental outcomes. The Babybe System is the only Class 1 medical device on the market aimed at improving the bonding experience during artificial incubation, which can lead to reduced healthcare costs and increased efficiency in neonatal intensive care units (NICUs). As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

QV Bioelectronics is focused on improving the lives of brain tumor patients through its innovative electric field therapy implant, GRACE. Developed in collaboration with leading neurosurgeons in the UK, GRACE aims to extend the life expectancy of glioblastoma patients, a group historically faced with limited treatment options and poor survival rates. Recognizing the urgent need for effective therapies, co-founders Dr. Richard Fu and Dr. Chris Bullock created a solution to address both the clinical and quality of life challenges faced by patients. The company has garnered nearly $1 million in funding from UK institutions, including Innovate UK, and over $1 million in equity funding from international life science investors. With a multidisciplinary team based in Alderley Park, Cheshire, QV Bioelectronics is dedicated to advancing GRACE from research to clinical application, utilizing cutting-edge materials science to enhance treatment outcomes for patients.

VoltStorage GmbH, based in Olching, Germany, specializes in developing and producing power storage devices that utilize eco-friendly redox flow technology. The company's flagship product, VoltStorage, is a vanadium redox flow battery system designed to store excess electricity generated by solar panels during the day for use at night. This innovative approach enables homeowners to access renewable energy around the clock, promoting sustainability and environmental responsibility. In addition to its products, VoltStorage offers installation and technical support services, ensuring customers can effectively integrate these systems into their homes. The company aims to make renewable energy more accessible and contribute to a cleaner, fairer world for future generations.

Arthronica Ltd is a London-based company that specializes in developing an artificial intelligence platform for patient monitoring and rehabilitation, particularly focused on chronic rheumatic conditions such as arthritis. Established in 2018, the company utilizes advanced technologies, including skeletal tracking, visual strength assessments, image analysis, and video analysis, to create solutions that assist medical practitioners in monitoring and predicting disease activities. Arthronica's innovative system incorporates force-sensing vision and 3D CAD modeling to measure swelling, thereby providing critical insights into disease progression. The company is actively engaged in clinical trials in both the United Kingdom and the United States to further validate its technology and enhance patient care. Additionally, Arthronica has participated in the Entrepreneur First program, which supports individuals in building technology companies.

DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in developing artificial intelligence-powered magnetic resonance imaging (MRI) equipment. The company’s innovative technology aims to provide MRI imaging systems that are significantly smaller, lighter, and more cost-effective than traditional models. By leveraging generative topological design and deep learning techniques, DeepSpin's MRI machines enhance accessibility to medical imaging, making it available to a wider range of patients globally. This approach seeks to improve healthcare standards in various medical fields previously lacking adequate imaging solutions.

Moona is a company focused on enhancing sleep quality through innovative technology. It offers a smart sleep device that regulates head temperature, adapting to the user’s needs throughout the night. The system, developed in 2016 and headquartered in Paris, France, utilizes a water-based cooling and heating mechanism within a thin membrane combined with memory foam. This design allows for a natural adjustment of body temperature, aiding users in falling asleep more comfortably. Additionally, Moona provides an online payment solution that offers customers a £5 discount on their purchases when using its service. For an annual subscription fee, users can enjoy unlimited discounts when shopping with Moona's retail partners, making it a cost-effective option for frequent shoppers.

Brightcure is solving the lack of treatment options available for patients suffering from recurrent urinary tract infections (UTIs). UTIs are one of world’s most common infections, affecting 50% of women and 12% of men worldwide. Current UTI treatments are not effective, can cause serious side effects, and often accelerate antibiotic-resistant infections. Total UTI costs currently amount over $ 8.6B per year. With UTI bacteria becoming increasingly difficult to treat, the size of the UTI market is expected to reach $ 12.41B by 2025. Brightcure utilizes the natural microbiome to reduce harmful bacteria and replenish the good bacteria in the vaginal flora. Brightcure’s bioactive intimate cream boosts the natural immune system to promote a healthy urinary tract. BrightCure was founded in 2019 and is headquartered in London, England. In 2020, BrightCure got a seed investment from SOSV and was selected as 1 out of 9 companies to be part of the world's largest biotech accelerator, Indiebio, to develop its first product. BrightCure has been selected as one of the Top 7 companies of the McKinsey Venture Challenge, Top 5 of the Mayor of London Competition, has won Imperial College's White City Innovation Program, and has taken part in the finals of ‘The Pitch’ London Competition being selected among 850 other applications.

EMYS is the most advanced, English speaking educational robot in the world with a friendly appearance and outstanding interactive capabilities. Children aged 3-7 years old simply love EMYS! The robot is a rich source of carefully chosen language presented through a series of interactive tasks, games, crafts, activities, songs and stories. The mission of EMYS Inc. is to shape the future of education through the world's most innovative, secure and hands-on technology. The EMYS team of highly qualified experts in the domains of English Language Education as well as Social Robotics pushes back the boundaries of Early Years Language Education programs. We are the first to combine modern research in language acquisition studies with Common European Framework requirements and the most advanced technology. Parents appreciate the assistance EMYS provides in getting kids constructively busy.They also observe a lasting engagement with language learning through the bond that children build with their robot. Children love learning with EMYS and quickly master the skills needed to play with their digital room-mate independently. EMYS' rich programme can be easily incorporated in diverse curricula. The included teachers’ books serve as inspiration for truly engaging classes. In EMYS classrooms worldwide there has been observed: - a significant increase in group focus - strengthened motivation in young learners - increased in-class satisfaction levels. EMYS is sold world-wide and our offices are located in the USA, Europe and Asia.

Brightcure is solving the lack of treatment options available for patients suffering from recurrent urinary tract infections (UTIs). UTIs are one of world’s most common infections, affecting 50% of women and 12% of men worldwide. Current UTI treatments are not effective, can cause serious side effects, and often accelerate antibiotic-resistant infections. Total UTI costs currently amount over $ 8.6B per year. With UTI bacteria becoming increasingly difficult to treat, the size of the UTI market is expected to reach $ 12.41B by 2025. Brightcure utilizes the natural microbiome to reduce harmful bacteria and replenish the good bacteria in the vaginal flora. Brightcure’s bioactive intimate cream boosts the natural immune system to promote a healthy urinary tract. BrightCure was founded in 2019 and is headquartered in London, England. In 2020, BrightCure got a seed investment from SOSV and was selected as 1 out of 9 companies to be part of the world's largest biotech accelerator, Indiebio, to develop its first product. BrightCure has been selected as one of the Top 7 companies of the McKinsey Venture Challenge, Top 5 of the Mayor of London Competition, has won Imperial College's White City Innovation Program, and has taken part in the finals of ‘The Pitch’ London Competition being selected among 850 other applications.

Machine Medicine Technologies Ltd is a healthcare company that develops an artificial intelligence platform designed to assess motor characteristics in Parkinson's disease patients using video clips. Its flagship product, KELVIN-PD, employs computer vision and pose estimation techniques to objectively track patient movements, capturing key metrics related to symptoms such as tremors and bradykinesia. This platform facilitates the secure storage and management of patient data and is accessible from any device, making it both affordable and user-friendly. Established in 2017 and headquartered in London, the company aims to enhance the understanding of the brain and advance neuro-therapeutics by providing interpretable tools for behavioral measurement.

Valanx Biotech GmbH, founded in 2017 and located in Klosterneuburg, Austria, specializes in the development and manufacture of synthetic programmable amino acids, particularly Norl. The company has created SnapIt, a reactive amino acid that facilitates the conjugation of antibodies with medicines, resulting in antibody-drug conjugates aimed at treating cancer. In addition to cancer therapy, Valanx's products are utilized for PEGylation of therapeutic peptides and proteins, as well as for the directed and oriented immobilization of biocatalysts and biosensors. The company also offers on-demand bioanalytics and mass spectrometry services. Valanx Biotech's site-specific protein conjugation platform aims to streamline the development of protein-drug conjugates, making the process faster and more cost-effective, ultimately allowing healthcare providers to produce receptor proteins with specific chemical modifications.

Multus is a London-based company established in 2019 that specializes in providing affordable and efficient growth media for the cultivated meat industry. By employing a machine learning approach, Multus develops entirely animal-free growth media tailored specifically for animal cells, helping cultivated meat companies scale their production while maintaining high performance. The company focuses on optimizing growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the environmental drawbacks associated with traditional animal serum-based media. This innovative solution supports the growth of diverse animal cell types and tissues, enabling clients to produce sustainable meat products while minimizing the environmental and economic impacts of conventional meat production.

Ester is an AI-platform that allows retailers to deliver hyper-personalized experiences. The platform is used by retailers and producers to create and market unique and differentiating gourmet foods. The company fuels customer-specific recommendations that allow retailers to provide personalized shopping experiences. With its platform, retailers can help customers explore the beer and wine aisle with confidence by pointing out products that match their taste preferences. Ester was founded in 2018 and is headquartered in Leuven, Belgium.

Metabolomic Diagnostics Ltd. is a medical diagnostics company based in Little Island, Ireland, founded in 2011. The company specializes in developing advanced diagnostic solutions that utilize mass spectrometry technology to analyze biomarkers associated with complex diseases. Its primary focus is on providing predictive diagnoses for pre-eclampsia in early pregnancy through a blood test that assesses the risk of this condition, which can lead to serious complications such as hypertension and restricted blood flow to the fetus. Metabolomic Diagnostics has established a pipeline for identifying diagnostic biomarker panels and translating these findings into clinical assays suitable for use in laboratory settings, thus enabling effective disease diagnosis and risk prediction.

Nordetect, based in Copenhagen and founded in 2016, is an analytical hardware company that specializes in Lab-on-a-chip devices designed for environmental and agricultural analysis. The company aims to integrate medical-grade technology into the farming sector, offering solutions for nutrient analysis to optimize crop performance. Nordetect's technology enables farm managers, agricultural service providers, and indoor growers to conduct reliable and affordable testing of soil nutrients, specifically nitrogen, phosphorus, and potassium. By providing clear and actionable data, the company helps users make informed decisions about fertilizer usage and agricultural practices, ultimately leading to improved harvests.

UNL is a technology company headquartered in Amsterdam, founded in 2018, that focuses on developing a micro-location infrastructure and mapping platform to create the Internet of Places. The company offers a unique geoID, allowing users to assign specific digital addresses to physical locations with a precision of 1x1cm². UNL's technology enhances physical spaces by integrating contextual data, which can be utilized across various sectors such as e-commerce, last-mile delivery, and smart city applications. The platform empowers businesses to create and manage their own Virtual Private Maps, enabling them to streamline services and improve efficiency. By providing decentralized and hyper-accurate mapping solutions, UNL facilitates innovative location-based applications, transforming the interaction between the physical and digital worlds.

DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in developing artificial intelligence-powered magnetic resonance imaging (MRI) equipment. The company’s innovative technology aims to provide MRI imaging systems that are significantly smaller, lighter, and more cost-effective than traditional models. By leveraging generative topological design and deep learning techniques, DeepSpin's MRI machines enhance accessibility to medical imaging, making it available to a wider range of patients globally. This approach seeks to improve healthcare standards in various medical fields previously lacking adequate imaging solutions.

viAct is an AI company focused on delivering scenario-based vision intelligence solutions for the architecture, engineering, and construction (AEC) industry across Asia, Europe, and the Middle East. Since its establishment in 2016, the company has successfully implemented hundreds of deployments, utilizing proprietary AI algorithms to provide detailed insights into job sites. viAct offers over 30 pre-built AI modules that help stakeholders enhance safety, reduce accidents, optimize costs, and monitor environmental compliance. Their applications track site activities, ensure adherence to safety measures, and identify irregularities, contributing to improved efficiency and personnel safety in construction projects.

Aō Air specializes in the manufacture and retail of advanced face masks aimed at providing clean air for individuals in polluted megacities such as Beijing and London. The company utilizes patented air purifying technology, which has been independently validated to be significantly more effective than traditional masks, filtering out dust and smoke particles through an active nanofiltration system. This innovative approach allows users to commute and exercise without the risks associated with pollution, promoting respiratory health while ensuring comfort and style. Aō Air's mission focuses on empowering urban residents to reclaim their environment and breathe clean air amidst increasing urban pollution challenges.

VoltStorage GmbH, based in Olching, Germany, specializes in developing and producing power storage devices that utilize eco-friendly redox flow technology. The company's flagship product, VoltStorage, is a vanadium redox flow battery system designed to store excess electricity generated by solar panels during the day for use at night. This innovative approach enables homeowners to access renewable energy around the clock, promoting sustainability and environmental responsibility. In addition to its products, VoltStorage offers installation and technical support services, ensuring customers can effectively integrate these systems into their homes. The company aims to make renewable energy more accessible and contribute to a cleaner, fairer world for future generations.

Valanx Biotech GmbH, founded in 2017 and located in Klosterneuburg, Austria, specializes in the development and manufacture of synthetic programmable amino acids, particularly Norl. The company has created SnapIt, a reactive amino acid that facilitates the conjugation of antibodies with medicines, resulting in antibody-drug conjugates aimed at treating cancer. In addition to cancer therapy, Valanx's products are utilized for PEGylation of therapeutic peptides and proteins, as well as for the directed and oriented immobilization of biocatalysts and biosensors. The company also offers on-demand bioanalytics and mass spectrometry services. Valanx Biotech's site-specific protein conjugation platform aims to streamline the development of protein-drug conjugates, making the process faster and more cost-effective, ultimately allowing healthcare providers to produce receptor proteins with specific chemical modifications.

Nordetect, based in Copenhagen and founded in 2016, is an analytical hardware company that specializes in Lab-on-a-chip devices designed for environmental and agricultural analysis. The company aims to integrate medical-grade technology into the farming sector, offering solutions for nutrient analysis to optimize crop performance. Nordetect's technology enables farm managers, agricultural service providers, and indoor growers to conduct reliable and affordable testing of soil nutrients, specifically nitrogen, phosphorus, and potassium. By providing clear and actionable data, the company helps users make informed decisions about fertilizer usage and agricultural practices, ultimately leading to improved harvests.

New Factory, founded in 2009 and based in Tampere, Finland, serves as an innovation platform and startup incubator. It facilitates connections among entrepreneurs, investors, industry experts, students, and researchers, both locally and internationally. The organization provides various services, including startup acceleration, access to co-working spaces, and opportunities for collaboration. By nurturing a supportive ecosystem, New Factory helps startups develop ideas, prototypes, and products while promoting essential skills and a collaborative mindset. Its mission is to empower entrepreneurs across diverse industries, enabling them to grow and succeed by implementing lean startup methodologies.

Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016 and based in Barcelona, Spain, the company specializes in creating non-invasive tests for the in-situ diagnosis of various cancers using patients' blood. It also develops in-vivo diagnosis systems that assist in surgical procedures and monitor patient conditions, alongside therapeutical drugs aimed at treating cancer. Moirai Biodesign's innovative pipeline includes RNA biomarker discovery, the design of plug-and-play bio devices, and advanced platform delivery systems, all aimed at improving early cancer detection and targeted treatment options.

Intelligent Implants, founded in 2014 in Cork, Ireland, specializes in the development of wireless implantable electronics designed to stimulate, steer, and monitor bone growth. The company focuses on creating electrotherapeutic devices that not only treat diseases but also support the recovery of bone and other tissues. By integrating data, engineering, and medicine, Intelligent Implants aims to deliver innovative, active, and connected medical devices that enhance patient treatment and facilitate decision-making for healthcare professionals. Their technology allows for the acceleration and adjustment of bone growth, enabling healthcare providers to effectively utilize electrotherapeutics to monitor and control patient conditions, ultimately leading to more timely and informed medical interventions.

Babybe GmbH is a medical device company based in Stuttgart, Germany, that specializes in products designed for premature babies and their mothers. Founded in 2013 by Raphael P. M. Lang and Camilo Anabalon, the company developed the Babybe System, a unique bionic mattress that simulates the mother's heartbeat, breathing, and voice, providing multisensory stimulation to preterm infants during their time in incubators. This innovative device facilitates a real-time connection between mother and child, enhancing the baby's recovery process and neurodevelopmental outcomes. The Babybe System is the only Class 1 medical device on the market aimed at improving the bonding experience during artificial incubation, which can lead to reduced healthcare costs and increased efficiency in neonatal intensive care units (NICUs). As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

ROVENSO is a Swiss startup from EPFL (Swiss Federal Institute of Technology Lausanne) incorporated in 2016.We are based near Lausanne (Switzerland). We develop, manufacture and market ROVéo, an agile robot for security and safety monitoring of industrial sites.ROVéo patrols fully autonomously 24/7, 2-3x more cost-effective than manned guarding, inside and outside industrial buildings, preventing intrusions, detecting any thefts of assets, but also detecting safety hazards such as start of fires, leaks or systems dysfunctions that could put people’s life at risks and that could be even missed by security guards.

Honeycomb is an API marketplace that connects smart contracts to external data inputs from premier data providers. Smart contracts can query APIs on Honeycomb via decentralized chainlink oracles, enabling the contract to execute in a reliable, end-to-end secure manner on networks like Ethereum, Bitcoin, and Hyperledger. Honeycomb reduces the amount of time smart contract developers spend searching for viable data sources, and increase the amount of time they spend building smart contracts. Honeycomb is headquartered in Munich, Germany.

Quidli is a technological infrastructure company based in Paris, France, that focuses on connecting companies and workers through the exchange of equity for labor. Founded in 2018, Quidli's platform allows businesses to split ownership equity as a form of compensation, facilitating a direct link between companies, freelancers, and investors. By leveraging blockchain technology, the platform provides a means for organizations to incentivize contributions from individuals, enhancing employee engagement and productivity. Additionally, it offers job security for workers by allowing them to pursue projects of their choice, while companies can utilize the platform for recruitment purposes.

QV Bioelectronics is focused on improving the lives of brain tumor patients through its innovative electric field therapy implant, GRACE. Developed in collaboration with leading neurosurgeons in the UK, GRACE aims to extend the life expectancy of glioblastoma patients, a group historically faced with limited treatment options and poor survival rates. Recognizing the urgent need for effective therapies, co-founders Dr. Richard Fu and Dr. Chris Bullock created a solution to address both the clinical and quality of life challenges faced by patients. The company has garnered nearly $1 million in funding from UK institutions, including Innovate UK, and over $1 million in equity funding from international life science investors. With a multidisciplinary team based in Alderley Park, Cheshire, QV Bioelectronics is dedicated to advancing GRACE from research to clinical application, utilizing cutting-edge materials science to enhance treatment outcomes for patients.